TrialJournal of the American Heart Association2026
Extended Anticoagulation Therapy With Rivaroxaban for Cancer-Associated Low-Risk Pulmonary Embolism According to Different Performance Status Scores: Insights From the ONCO PE Randomized Trial.
Wei Xiong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.